Literature DB >> 15259508

Risk factors for hepatocellular carcinoma in patients with cirrhosis.

Steedman A Sarbah1, Terry Gramlich, Abraham Younoszai, Pat Osmack, Marlene Goormastic, Leonard Grosso, James N Cooper, Adrian Di Bisceglie, Russell Seneca, Zobair M Younossi.   

Abstract

Recent research suggests an increase in the incidence of hepatocellular carcinoma (HCC) in the United States, which may be related to an upsurge in the sequelae of chronic liver disease from hepatitis C virus. In addition to factors related to the underlying etiology of liver disease, a number of host factors such as age, gender, and ethnic background may be associated with this increased risk. The aim of this study was to evaluate a number of potential risk factors for HCC in patients with cirrhosis. Patients with biopsy proven HCC were identified from our pathology and cancer registry databases. All those without histologic or clinical cirrhosis and non-HCC hepatic malignancies were excluded. Cirrhotic patients without HCC were also selected from the Cleveland Clinic unified transplant database and were designated controls. Extensive clinicodemographic data were obtained from the databases and chart reviews. When available, paraffin-embedded liver biopsy blocks were obtained for HFE gene analysis. Univariate comparisons were made with chi-square and Fisher's exact test and multivariate analysis was carried out with logistic regression. A total of 760 patients were included in this study, 244 documented cases of HCC and 516 cirrhotic controls without HCC. Patients' age (RR = 3.1 [2.6-3.8]; P < 0.0001), male gender (RR = 3.4 [2.3-5.1]; P < 0.0001), African-American ethnicity (RR = 3.1 [1.6-5.8]; P = 0.0005), and other non-Caucasian ethnicity (RR = 6.9 [3.2-14.4]; P < 0.0001) were independently associated with HCC. Restricting the analysis to HCV-related cirrhosis, the same risk factors remained independently associated with HCC: age (decade; RR = 2.3 [1.6-3.4]; P < 0.0001), male gender (RR = 2.9 [1.2-7.0]; P = 0.02), African-American ethnicity (RR = 3.1 [1.3-7.4]; P = 0.009), and other non-Caucasian ethnicity (RR = 15.8 [1.9-134]; P = 0.01). Iron studies did not reveal an increased risk for iron overload or HFE mutation. Male gender, advancing age, and non-Caucasian ethnic background are independently associated with HCC.

Entities:  

Mesh:

Year:  2004        PMID: 15259508     DOI: 10.1023/b:ddas.0000030098.75759.32

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  11 in total

Review 1.  Hepatitis C in African Americans: summary of a workshop.

Authors:  C Howell; L Jeffers; J H Hoofnagle
Journal:  Gastroenterology       Date:  2000-11       Impact factor: 22.682

2.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Authors:  M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

Review 3.  Hepatocellular carcinoma.

Authors:  M P Manns; S Kubicka
Journal:  Digestion       Date:  1997       Impact factor: 3.216

Review 4.  Hepatocellular carcinoma.

Authors:  D F Schafer; M F Sorrell
Journal:  Lancet       Date:  1999-04-10       Impact factor: 79.321

5.  The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy Group.

Authors:  J G McHutchison; T Poynard; S Pianko; S C Gordon; A E Reid; J Dienstag; T Morgan; R Yao; J Albrecht
Journal:  Gastroenterology       Date:  2000-11       Impact factor: 22.682

6.  Hepatitis C virus infection is associated with the development of hepatocellular carcinoma.

Authors:  I Saito; T Miyamura; A Ohbayashi; H Harada; T Katayama; S Kikuchi; Y Watanabe; S Koi; M Onji; Y Ohta
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

7.  Rising incidence of hepatocellular carcinoma in the United States.

Authors:  H B El-Serag; A C Mason
Journal:  N Engl J Med       Date:  1999-03-11       Impact factor: 91.245

8.  Factors influencing waiting time and successful receipt of cadaveric liver transplant in the United States. 1990 to 1992.

Authors:  A C Klassen; D K Klassen; R Brookmeyer; R G Frank; K Marconi
Journal:  Med Care       Date:  1998-03       Impact factor: 2.983

9.  Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population.

Authors:  M Sherman; K M Peltekian; C Lee
Journal:  Hepatology       Date:  1995-08       Impact factor: 17.425

Review 10.  Viral hepatitis and hepatocellular carcinoma.

Authors:  R Sallie; A M Di Bisceglie
Journal:  Gastroenterol Clin North Am       Date:  1994-09       Impact factor: 3.806

View more
  15 in total

1.  Rapid genotyping of hepatitis C virus by primer-specific extension analysis.

Authors:  Nick A Antonishyn; Vivian M Ast; Ryan R McDonald; Rabindra K Chaudhary; Lisa Lin; Anton P Andonov; Greg B Horsman
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

2.  Alterations of glycan branching and differential expression of sialic acid on alpha fetoprotein among hepatitis patients.

Authors:  Gautam Mondal; Urmimala Chatterjee; Yogesh K Chawla; Bishnu Pada Chatterjee
Journal:  Glycoconj J       Date:  2010-12-14       Impact factor: 2.916

3.  Novel changes in glycosylation of serum Apo-J in patients with hepatocellular carcinoma.

Authors:  Mary Ann Comunale; Mengjun Wang; Lucy Rodemich-Betesh; Julie Hafner; Anne Lamontagne; Andrew Klein; Jorge Marrero; Adrian M Di Bisceglie; Robert Gish; Timothy Block; Anand Mehta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04-05       Impact factor: 4.254

4.  Increased levels of tetra-antennary N-linked glycan but not core fucosylation are associated with hepatocellular carcinoma tissue.

Authors:  Anand Mehta; Pamela Norton; Hongyan Liang; Mary Ann Comunale; Mengjun Wang; Lucy Rodemich-Betesh; Alex Koszycki; Katsuhisa Noda; Eiji Miyoshi; Timothy Block
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-04-06       Impact factor: 4.254

5.  Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma.

Authors:  Mary Ann Comunale; Lucy Rodemich-Betesh; Julie Hafner; Mengjun Wang; Pamela Norton; Adrian M Di Bisceglie; Timothy Block; Anand Mehta
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

6.  Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma.

Authors:  Mengjun Wang; Ronald E Long; Mary Ann Comunale; Omer Junaidi; Jorge Marrero; Adrian M Di Bisceglie; Timothy M Block; Anand S Mehta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05-19       Impact factor: 4.254

7.  Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.

Authors:  Gautam Mondal; Ashish Saroha; Partha Pratim Bose; B P Chatterjee
Journal:  Glycoconj J       Date:  2016-03-31       Impact factor: 2.916

8.  Prognostic factors of hepatocellular carcinoma patients treated by transarterial chemoembolization.

Authors:  Jun Xiao; Guojian Li; Shuhan Lin; Ke He; Hao Lai; Xianwei Mo; Jiansi Chen; Yuan Lin
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

9.  Progression of liver cirrhosis to HCC: an application of hidden Markov model.

Authors:  Nicola Bartolomeo; Paolo Trerotoli; Gabriella Serio
Journal:  BMC Med Res Methodol       Date:  2011-04-04       Impact factor: 4.615

10.  A multicenter retrospective study on clinical characteristics, treatment patterns, and outcome in elderly patients with hepatocellular carcinoma.

Authors:  Olga N Kozyreva; Dorcas Chi; Jeffrey W Clark; Hejing Wang; Kathy P Theall; David P Ryan; Andrew X Zhu
Journal:  Oncologist       Date:  2011-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.